Stock APPLIED DNA SCIENCES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Applied DNA Sciences Inc OTC Bulletin Board

Equities

US03815U1025

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Applied DNA Sciences Inc
06-20 Applied DNA Sciences, Inc. and Alphazyme LLC Conclude Linea (TM) RNAP Manufacturing Scale-Up Project, Deliver Substantial Improvement in Linea (TM) IVT Platform Economics CI
06-18 Applied DNA Partners With GenXys For Pharmacogenetic Testing MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Applied DNA and Alphazyme Conclude Linea RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea IVT Platform Economics
AQ
Applied DNA Sciences, Inc. and Alphazyme LLC Conclude Linea (TM) RNAP Manufacturing Scale-Up Project, Deliver Substantial Improvement in Linea (TM) IVT Platform Economics
CI
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic Testing
AQ
Applied DNA Partners With GenXys For Pharmacogenetic Testing
MT
Applied DNA Sciences : Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
PU
Applied DNA Sciences, Inc. Receives Approval for TR8(TM) Pharmacogenomic Testing Service from New York State Department of Health
CI
HC Wainwright Adjusts Applied DNA Sciences Price Target to $1.50 From $7, Maintains Buy Rating
MT
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea IVT Platform
AQ
Applied DNA Announces Pricing of $12 Million Public Offering
AQ
Applied DNA Sciences May Seek Potential Acquisitions
CI
US Equities Markets Close Mixed Tuesday as Nvidia Propels Nasdaq to Record High
MT
Top Midday Decliners
MT
Applied DNA Sciences Prices $12 Million Public Offering of Units
MT
Maxim Downgrades Applied DNA Sciences to Hold From Buy
MT
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
AQ
Top Premarket Decliners
MT
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot
AQ
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q2 Revenue $929,631
MT
Applied DNA Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
CI
Applied DNA Sciences Regains Nasdaq Minimum Bid Price Requirement
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APDN Stock
  4. Stock
  5. News Applied DNA Sciences Inc